THE ULTIMATE GUIDE TO MBO128

Emily Bodnar’s ranking is based over the anticipation of important milestones for Agenus in the approaching calendar year, specifically the opportunity submitting of a Biologics License Software (BLA) for his or her guide drug candidate, botensilimab (bot). Agenus has dosed above 900 sufferers with bot across a variety of good tumors, showing a c